ClinVar Genomic variation as it relates to human health
NM_001077365.2(POMT1):c.1837_1852dup (p.Gly618fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001077365.2(POMT1):c.1837_1852dup (p.Gly618fs)
Variation ID: 655295 Accession: VCV000655295.9
- Type and length
-
Duplication, 16 bp
- Location
-
Cytogenetic: 9q34.13 9: 131522050-131522051 (GRCh38) [ NCBI UCSC ] 9: 134397437-134397438 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Aug 14, 2019 Feb 28, 2024 Apr 30, 2019 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001077365.2:c.1837_1852dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001070833.1:p.Gly618fs frameshift NM_001077366.2:c.1675_1690dup NP_001070834.1:p.Gly564fs frameshift NM_001136113.2:c.1837_1852dup NP_001129585.1:p.Gly618fs frameshift NM_001136114.2:c.1486_1501dup NP_001129586.1:p.Gly501fs frameshift NM_001353193.2:c.1903_1918dup NP_001340122.2:p.Gly640fs frameshift NM_001353194.2:c.1675_1690dup NP_001340123.1:p.Gly564fs frameshift NM_001353195.2:c.1486_1501dup NP_001340124.1:p.Gly501fs frameshift NM_001353196.2:c.1747_1762dup NP_001340125.1:p.Gly588fs frameshift NM_001353197.2:c.1741_1756dup NP_001340126.2:p.Gly586fs frameshift NM_001353198.2:c.1741_1756dup NP_001340127.2:p.Gly586fs frameshift NM_001353199.2:c.1552_1567dup NP_001340128.2:p.Gly523fs frameshift NM_001353200.2:c.1381_1396dup NP_001340129.1:p.Gly466fs frameshift NM_001374689.1:c.1825_1840dup NP_001361618.1:p.Gly614fs frameshift NM_001374690.1:c.1618_1633dup NP_001361619.1:p.Gly545fs frameshift NM_001374691.1:c.1486_1501dup NP_001361620.1:p.Gly501fs frameshift NM_001374692.1:c.1486_1501dup NP_001361621.1:p.Gly501fs frameshift NM_001374693.1:c.1486_1501dup NP_001361622.1:p.Gly501fs frameshift NM_001374695.1:c.1447_1462dup NP_001361624.1:p.Gly488fs frameshift NM_007171.3:c.1903_1918dup16 frameshift NM_007171.4:c.1903_1918dup NP_009102.4:p.Gly640fs frameshift NR_148391.2:n.1871_1886dup non-coding transcript variant NR_148392.2:n.2089_2104dup non-coding transcript variant NR_148393.2:n.2010_2025dup non-coding transcript variant NR_148394.2:n.1764_1779dup non-coding transcript variant NR_148395.2:n.2162_2177dup non-coding transcript variant NR_148396.2:n.1796_1811dup non-coding transcript variant NR_148397.2:n.1921_1936dup non-coding transcript variant NR_148398.2:n.1876_1891dup non-coding transcript variant NR_148399.2:n.2402_2417dup non-coding transcript variant NR_148400.2:n.2001_2016dup non-coding transcript variant NC_000009.12:g.131522058_131522073dup NC_000009.11:g.134397445_134397460dup NG_008896.1:g.24157_24172dup LRG_842t1:c.1903_1918dup LRG_842p1:p.Gly640fs LRG_842t2:c.1837_1852dup LRG_842p2:p.Gly618fs - Protein change
- G545fs, G488fs, G501fs, G523fs, G614fs, G618fs, G466fs, G564fs, G586fs, G640fs, G588fs
- Other names
- -
- Canonical SPDI
- NC_000009.12:131522050:CTGGCTGCGCTGGGTGCTGGCTG:CTGGCTGCGCTGGGTGCTGGCTGCGCTGGGTGCTGGCTG
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
POMT1 | - | - |
GRCh38 GRCh37 |
1161 | 1202 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Apr 30, 2019 | RCV000811436.9 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Apr 30, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
Walker-Warburg congenital muscular dystrophy Autosomal recessive limb-girdle muscular dystrophy type 2K
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000951703.6
First in ClinVar: Aug 14, 2019 Last updated: Feb 28, 2024 |
Comment:
This sequence change results in a premature translational stop signal in the POMT1 gene (p.Gly640Alafs*96). While this is not anticipated to result in nonsense mediated … (more)
This sequence change results in a premature translational stop signal in the POMT1 gene (p.Gly640Alafs*96). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 108 amino acids of the POMT1 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with POMT1-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant disrupts the C-terminus of the POMT1 protein. Other variant(s) that disrupt this region (p.Asp723Glyfs*8) have been determined to be pathogenic (PMID: 12369018, 22323514, 17559086, 16575835, 24491487, 24304607). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. | Wallace SE | Neuromuscular disorders : NMD | 2014 | PMID: 24491487 |
Detection limit of intragenic deletions with targeted array comparative genomic hybridization. | Askree SH | BMC genetics | 2013 | PMID: 24304607 |
Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. | Devisme L | Brain : a journal of neurology | 2012 | PMID: 22323514 |
Molecular heterogeneity in fetal forms of type II lissencephaly. | Bouchet C | Human mutation | 2007 | PMID: 17559086 |
The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. | van Reeuwijk J | Human mutation | 2006 | PMID: 16575835 |
Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. | Beltrán-Valero de Bernabé D | American journal of human genetics | 2002 | PMID: 12369018 |
Text-mined citations for rs1315540509 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.